semaglutide patent expiration us 2031 The Heavy Price of GLP-1 Drugs – I-MAK The Heavy Price of GLP-1

Q4 2024 Results

Its doseresponse relationships with respect to side effects, safety, and efficacy for the treatment of obesity.

The WHO released its first global guideline for GLP-1 obesity treatment, recognizing obesity as a chronic disease

Our breakthrough patch is a non-invasive, pain-free alternative to traditional GLP-1 injectionsproviding powerful support for weight management, blood sugar stabilization, and type 2 diabetes treatment, without the discomfort or inconvenience of needles

Enhanced with digestive enzymes

Dies ermglicht es, die Menge an konsumiertem Ingwer zu reduzieren, von 2-4 g auf 200 mg des Ingwerextrakts Ginfort, der mit 26 % Gingerolen standardisiert ist